HROW Q4 2023 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q4 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$36M+78.8% YoY

Gross Profit

$25M68.9% margin

Operating Income

-$5M-13.4% margin

Net Income

-$9M-25.2% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+6.1%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$8M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$312M

Total Liabilities

$242M

Stockholders' Equity

$70M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$20M	+78.8%
Gross Profit	$25M	$14M	+76.9%
Operating Income	-$5M	-$2M	-174.2%
Net Income	-$9M	$1M	-967.1%